Cargando…
The PI3K/Akt/mTOR pathway in lung cancer; oncogenic alterations, therapeutic opportunities, challenges, and a glance at the application of nanoparticles
Lung cancer is the leading cause of cancer-related mortality worldwide. Although the PI3K/Akt/mTOR signaling pathway has recently been considered as one of the most altered molecular pathways in this malignancy, few articles reviewed the task. In this review, we aim to summarize the original data ob...
Autores principales: | Sanaei, Mohammad-Javad, Razi, Sara, Pourbagheri-Sigaroodi, Atieh, Bashash, Davood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850794/ https://www.ncbi.nlm.nih.gov/pubmed/35168143 http://dx.doi.org/10.1016/j.tranon.2022.101364 |
Ejemplares similares
-
Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination
por: Delshad, Mahda, et al.
Publicado: (2022) -
PI3K Abrogation Using Pan-PI3K Inhibitor BKM120 Gives Rise to a Significant Anticancer Effect on AML-Derived KG-1 Cells by Inducing Apoptosis and G2/M Arrest
por: Sadeghi, Soroush, et al.
Publicado: (2020) -
Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities
por: Moradinasab, Susan, et al.
Publicado: (2021) -
Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity
por: Delshad, Mahda, et al.
Publicado: (2021) -
Laboratory findings in COVID-19 diagnosis and prognosis
por: Pourbagheri-Sigaroodi, Atieh, et al.
Publicado: (2020)